Skip to main content
. 2021 Mar 25;13(7):1521. doi: 10.3390/cancers13071521

Figure 2.

Figure 2

The role of Axl in resistance to epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2) and HER3 tyrosine kinase inhibitors.